Atossa Therapeutics
ATOS
#9757
Rank
A$66.54 M
Marketcap
A$7.73
Share price
10.46%
Change (1 day)
575.59%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -A$46.92 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$35.9 Million, an increase over its 2023 earnings that were of -A$42.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$46.92 Million30.7%
2024 -A$35.9 Million-15.25%
2023 -A$42.37 Million11.62%
2022 -A$37.95 Million30.84%
2021 -A$29.01 Million15.58%
2020 -A$25.1 Million3.41%
2019 -A$24.27 Million51.16%
2018 -A$16.06 Million40.41%
2017 -A$11.44 Million27.54%
2016 -A$8.97 Million-47.49%
2015 -A$17.08 Million-17.25%
2014 -A$20.64 Million35.91%
2013 -A$15.19 Million112.3%
2012 -A$7.16 Million46.53%
2011 -A$4.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.60 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.81 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.87 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$58.67 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-A$0.16 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$11.04 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA